GL1X · GenesisL1 explorer

Research workbench

3'-deoxy modification at 3' end of RNA primer complex with guanosine dinucleotide ligand G(5')PPP(5')G

Analyse 3'-deoxy modification at 3' end of RNA primer complex with guanosine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LNF
Type
RNA
Length
26 nucleotides
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*(GDO))-3')
Ligands
GDO, GP3, MG, CO
Pockets
1 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*(GDO))-3')rna13——

Ligands and binding sites

  • GDO · 3'-deoxy-guanosine 5'-monophosphate · ligand · 2 copies · chains A, B
  • GP3 · Diguanosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 8 copies · chains A, B
  • CO · Cobalt (II) ion · metal · 2 copies

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13270.490.7321MG

Interfaces

1 interface between chains.

  • A–B · 680 Ų buried · 39 hydrogen bonds · nucleic-nucleic

Modifications

Observed in the structure: 8 modified, 2 covalent (nucleotide modification, covalent ligand).

Compared structures

  • 7LNF · 3'-deoxy modification at 3' end of RNA primer complex with guanosine dinucleotide ligand… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.